Sarcoma Cancers

Currently Available Clinical Trials from Georgetown Lombardi:

Sarcomas
Hermatology
Pediatric Oncology

More clinical trials are available on NIH’s national clinical trial database and Lombardi’s clinical trials resources.

Lombardi CancerLine
(202) 444-4000

Pediatric Hematology/Oncology

You will be redirected to our clinical partner, MedStar Georgetown University Hospital.

About the Cancer

Georgetown Lombardi is committed to providing you with the most current information and resources available on Sarcomas, including but not limitied to: Adult Soft Tissue, Osteosarcoma (Bone Cancer), Rhabdomyosarcoma, Ewing’s Family of Tumors and Pedicatric Sarcomas. Please see the links below for more information.

Current information about sarcoma cancers, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research, are available online from the National Cancer Institute (new window) at the National Institutes of Health (new window).

Learn more about the types of bone cancer (new window) including sarcoma (new window), soft tissue sarcoma (new window) and sarcoma treatments (new window) available at MedStar Georgetown University Hospital.

What We Offer

  • For Sarcoma Cancer Services at Lombardi, call the Lombardi CancerLine at (202) 444-4000 to speak with a registered nurse, certified in oncology, who can give you the information you need to find a doctor, ask questions about risk, second opinions, symptoms, cancer screenings or treatment options.
  • Pediatric Hematology/Oncology Services at Lombardi
  • Patient and Family Resources
  • Clinical Trials. Through the MedStar Health network, MedStar Lombardi/Georgetown University Hospital, we are pleased to offer you access to our cutting-edge clinical trials. Search clinical trails | Learn more about clinical trials.

Cancer Research

Georgetown Lombardi’s world-renowned Research Faculty are discovering cancer risk factors, designing effective prevention strategies, and learning how to detect cancers earlier. They are developing and testing the cancer treatments of tomorrow – targeted therapies that will improve both survival and quality of life. They are making progress toward the ultimate goal: to eradicate cancer.